1.
The Construction and Characterization of Human Prourokinase Mutant;
人尿激酶原突变体的构建与特性分析
2.
Expression of Human Prourokinase Mutant in the Milk of Goat Mediated by the Recombinant Adenovirus
重组腺病毒介导的人尿激酶原突变体在山羊乳汁中的表达
3.
Construction of Recombinant Lentivirus Expression Vector Expressing Human pro-Urokinase Mutant Specific for Mammary Gland of Goats
表达人尿激酶原突变体的重组山羊乳腺特异性表达慢病毒载体的构建
4.
Study on the Transcriptional Regulation of Urokinase Plasminogen Activator in Human Lung Cancer;
尿激酶型纤溶酶原激活物在人肺癌细胞中表达调控的研究
5.
Effects of Human Urinary Kallidinogenase on Collateral Circulation in Patients with Acute Cerebral Infarction
人尿激肽原酶对急性脑梗死侧枝循环的影响
6.
An enzyme in human urine that catalyzes the conversion of plasminogen to plasmin and is used in medicine to dissolve blood clots.
尿激酶人体尿液中的可促使血将酶原转代成血浆酶的酶，用于溶解血凝块的药物中
7.
Study on Recombinant Nonglycosylated Urokinase-type Plasminogen Activator;
重组非糖基化尿激酶型纤溶酶原激活剂的研究
8.
A Study on the Treatment of Primary Intraventricular Hemorrhage in Adults by Intraventricular Hemorrhage in Adults by Intraventricular Infusion of Urokinase with Low Venrticular Drainage;
脑室低位引流并尿激酶灌注治疗成人原发性脑室出血的研究
9.
The Clinical Evaluation and fMRI(DWI,PWI) Study of Human Urinary Kallidinogenase in Treatment of Acute Cerebral Infarction
人尿激肽原酶治疗急性脑梗死的临床与MR弥散灌注显像研究
10.
Effects of Different Concentration of Human Urinary Kallikrein on Blood Pressure in the Treatment of Acute Cerebral Infarction
不同浓度人尿激肽原酶治疗急性脑梗死对患者血压的影响研究
11.
Expression and Prognostic Significance of Nuclear Factor-kappaBp-65 and uPA in Cervical Carcinoma;
核转录因子-kBp65和尿激酶型纤溶酶原激活剂在人宫颈癌中的表达及预后意义
12.
The Expression of uPA and Endostatin in Human Colorectal Carcinoma and Their Relations to Angiogenesis;
人大肠肿瘤中尿激酶型纤溶酶原激活物和内皮抑素的表达与血管新生的关系
13.
Comparison of Recombinant Tissue Plasminogen Activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test
重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较
14.
Cloning and Expression of Urokinase Type Plasminogen Activator cDNA
尿激酶型纤溶酶原激活因子cDNA的克隆与原核表达
15.
Clinical Study of the Expression of Tissue Factor and Urokinase Plasminogen Activator Receptor in Breast Cancer
组织因子、尿激酶型纤溶酶原激活剂受体在乳腺癌中的表达
16.
Clinical Significance of Measurement of Plasma Urokinase Type Plasminogen Activator and its Receptor in Cancer Patients
癌症患者尿激酶型纤溶酶原激活物及其受体检测的临床意义
17.
The Relationship between the Expression of Yrokinase-type Plasminogen Activator Receptor,and the Infiltration and Metastasis of Gastric Cancer
尿激酶型纤溶酶原激活物受体表达与胃癌浸润和转移过程的关系
18.
Expression of urokinase-type plasminogen activator and its receptor protein in synovial tissues from osteoarthritis
骨关节炎滑膜中尿激酶型纤溶酶原激活物及其受体蛋白的表达